Navigation Links
OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
Date:2/12/2013

www.OncoGenex.com.

OncoGenex' Forward Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial completion and design and statements regarding the potential benefits and potential development of our product candidates. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk that our product candidates will not demonstrate the hypothesized or expected benefits, the risk of delays in our expected clinical trials, the risk that new developments in the rapidly evolving cancer therapy landscape require changes in our clinical trial plans or limit the potential benefits of our product, the risk that our cash resources are insufficient to fund our planned activities for the time period expected and the other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
2. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Colo. , July 27, 2015 /PRNewswire/ ... report financial results for the fourth quarter ... hold a conference call to discuss those ... Squarer, Chief Executive Officer will lead the ... a.m. Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: 68380312 ...
(Date:7/27/2015)... 27, 2015 As per the new ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 ... billion in 2014, growing at a CAGR of 13.2% from ... 2021. The global bionics market is growing primarily ... is leading to paralysis or amputation of body parts. In ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ) has ... in Asia/Pacific Markets Seminar" conference to their offering. ... market is well established, the next growth area is ... , together with other countries in this region have ... their own medical device regulations. This seminar will provide ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... PDS Biotechnology Corporation today,announced that the company ... the US,National Cancer Institute,s Nanotechnology Characterization Lab ... to filing of,the Investigational New Drug Application. ... biological studies on behalf of the company ...
... completed a clinical safety report from a large Phase ... the excellent,safety profile of IMVAMUNE(R). Within the next few ... to the FDA and this will trigger a USD ... safety,report constitutes a major part of the data package ...
Cached Medicine Technology:PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R) 2
(Date:7/28/2015)... ... 2015 , ... Women fear developing Alzheimer's disease more than having a heart ... stroke are treatable, but there is little an individual can do to arrest the ... a clinical trial, reports the July 2015 Harvard Women's Health Watch . , ...
(Date:7/28/2015)... ... , ... A new study published by HealthDay News on June 24, 2015, ... a possible new treatment option for people living with fibromyalgia – hyperbaric oxygen therapy ... five per week, patients experienced a significant decrease in pain, fatigue, and other symptoms ...
(Date:7/28/2015)... IN (PRWEB) , ... July 28, 2015 , ... Most ... released from the 2014 UBA Health Plan Survey shows a significant increase in the ... major increases in corresponding median copays -- a trend that is expected to continue, ...
(Date:7/28/2015)... ... July 28, 2015 , ... PeopleKeys ... the regional winner of the EY Entrepreneur of the Year award. The award ... of home healthcare, and the innovative work they have done in incorporating new ...
(Date:7/28/2015)... Maryland (PRWEB) , ... July 28, 2015 , ... Maryland ... (MBSP) – and, along with it, more service offerings, updated treatment techniques, and ... leading authority for pain management and minimally invasive surgical treatment of brain and spine ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4
... discover gender differences that explain the aging inequity ... discovered yet another gender inequity: Women develop more and ... men do. , The disadvantage had long been suspected, ... Dr. Foad Nahai, a plastic surgeon practicing in Atlanta ...
... , , GAINESVILLE, Fla., Dec. 17 Over the last ... scare language that is used by e cigarette opposition in an ... questioning the tactics of these groups when the evidence clearly shows ... to several studies, lab reports and opinions from top medial and ...
... , , HOUSTON, ... Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin ... for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic ... late-stage development - the rights to which have been ...
... ... the nearly one-in-three American adults who serve as a family caregiver , ... Arlington, VA (PRWEB) December 17, 2009 -- The ... 2009 , which offers a revealing portrait of the nearly one-in-three American adults who serve ...
... ... Google Local and in front of their local customers by establishing a simple and ... Internet Marketing. , ... New Orleans, LA (PRWEB) December 17, 2009 -- In order to be competitive locally ...
... , ... Using new marketing techniques, life coaching company puts free i-phone & i-touch application ... , ... (PRWEB) December 17, 2009 -- Utah based Attainment Life Management & Coaching is ...
Cached Medicine News:Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: